Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BP CRUSH: Azor in Hypertensive Non-Responders
NCT00791258Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olmesartan, amlodipine in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd.. Started Nov 2008; status: completed.
02
Drugs
olmesartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00791258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00791258.